Companies

SenesTech, Inc.

SNES · CIK 0001680378 · operating

$2.21-3.70%Last updated Feb 27, 8:53 PM

Key Statistics

Valuation

Market Cap$11.75M
P/E
Fwd P/E-0.50
PEG
P/S5.11
P/B1.04
EV/EBITDA-0.73
EV/Rev1.82

Profitability

Gross Margin54.07%
Op. Margin-336.51%
Net Margin-333.01%
ROE-246.28%
ROA-188.65%
FCF Margin-329.40%

Financial Health

Current Ratio5.01
Debt/Equity0.31
Free Cash Flow-$6.12M
Div. Yield

Growth & Other

Revenue Growth55.66%
EPS Growth23.02%
Beta0.21
52W High$6.24
52W Low$1.3

About SenesTech, Inc.

SenesTech develops and commercializes fertility control technology for managing rodent pest populations. The company's primary product, ContraPest, is a liquid bait formulation containing 4-vinylcyclohexene diepoxide and triptolide that reduces reproductive capacity in rats. The company also offers Evolve, a soft bait containing cottonseed oil designed to limit reproduction in both male and female rats after initial breeding cycles, and Evolve Mouse, a variant formulated for mice that achieves reproductive effects within one to two breeding cycles following consumption.

In addition to its bait products, SenesTech provides teleconsulting and technical advisory services to support customer implementation and pest management outcomes. The company targets agricultural, commercial, and industrial customers seeking alternatives to traditional rodent control methods.

SenesTech operates with a lean organizational structure of 23 full-time employees and is headquartered in Phoenix, Arizona. The company was incorporated in Delaware in 2004 and trades on the Nasdaq exchange. Its revenue scale and specific geographic distribution of sales are not disclosed in available data.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-8.86$-8.86+23.0%
2023$-11.51$-11.51+25.7%
2022$-15.50$-15.50
2021
2020
2019
2018
2017

Annual Reports (10-K) · 9 filings

Report DateFiledAccession Number
2024-12-312025-03-130001628280-25-012408SEC ↗
2023-12-312024-02-210001628280-24-005919SEC ↗
2022-12-312023-03-170001628280-23-008353SEC ↗
2021-12-312022-03-290001213900-22-015848SEC ↗
2020-12-312021-03-290001213900-21-018287SEC ↗
2019-12-312020-03-170001213900-20-006565SEC ↗
2018-12-312019-03-290001615774-19-004827SEC ↗
2017-12-312018-03-300001615774-18-002215SEC ↗
2016-12-312017-03-310001144204-17-017841SEC ↗